The industry raised about $15.1 billion from all sources in 2001, less than half the $37.6 million raised in 2000 but still the second best year for biotechnology financing. The book includes every financing deal from last year, as well as a complete listing of all collaborations, stock data and actions taken by the FDA.

The 379-page report also reports on the scientific progress, Wall Street performances and government actions that shaped 2001, and looks ahead to the issues likely to impact the biotech sector in 2002. To purchase a copy of the BioWorld Biotechnology State of the Industry Report 2002, call (800) 688-2421 or (404) 262-5476, or visit www.bioworld.com.